Cancer Cell Biology
The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity
Echeverria and colleagues compare the proteome in normal and oncogenically transformed NIH-3T3 cells treated with Hsp90 inhibitors. Their study sheds light on why cancer cells are more sensitive to these inhibitors than normal cells.
Image credit: pone.0208287